Abstract
A robust bioinformatics capability is widely acknowledged as central to realizing the promises of toxicogenomics. Successful application of toxicogenomic approaches, such as DNA microarrays, inextricably relies on appropriate data management, the ability to extract knowledge from massive amounts of data, and the availability of functional information for data interpretation. At the FDA’s National Center for Toxicological Research (NCTR), we are developing a public microarray data management and analysis software, called ArrayTrack, that is also used in the routine review of genomic data submitted to the FDA. ArrayTrack stores a full range of information related to DNA microarrays and clinical and non-clinical studies as well as the digested data derived from proteomics and metabonomics experiments. In addition, ArrayTrack provides a rich collection of functional information about genes, proteins, and pathways drawn from various public biological databases for facilitating data interpretation. Many data analysis and visualization tools are available with ArrayTrack for individual platform data analysis, multiple omics data integration, and integrated analysis of omics data with study data. Importantly, gene expression data, functional information, and analysis methods are fully integrated so that the data analysis and interpretation process is simplified and enhanced. Using ArrayTrack, users can select an analysis method from the ArrayTrack tool box, apply the method to selected microarray data, and the analysis of results can be directly linked to individual gene, pathway, and Gene Ontology analysis. ArrayTrack is publicly available online (http://www.fda.gov/nctr/science/centers/toxicoinformatics/ArrayTrack/index.htm) and the prospective user can also request a local installation version by contacting the authors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Disclaimer: The views presented in this article do not necessarily reflect those of the US Food and Drug Administration
References
Schmidt, C.W. (2002) Toxicogenomics: an emerging discipline. Environ. Health Perspect., 110, A750–A755.
Afshari, C.A., Nuwaysir, E.F. and Barrett, J.C. (1999) Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res., 59,4759–4760.
Nuwaysir, E.F., Bittner, M., Trent, J., Barrett, J.C. and Afshari, C.A. (1999) Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog., 24,153–159.
Hamadeh, H.K., Amin, R.P., Paules, R.S. and Afshari, C.A. (2002) An overview of toxicogenomics. Curr. Issues Mol. Biol., 4,45–56.
Tong, W., Cao, X., Harris, S., Sun, H., Fang, H., Fuscoe, J., Harris, A., Hong, H., Xie, Q., Perkins, R., Shi, L. and Casciano, D. (2003) ArrayTrack – supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ. Health Perspect., 111,1819–1826.
Frueh, F.W. (2006) Impact of microarray data quality on genomic data submissions to the FDA. Nat. Biotechnol., 24,1105–1107.
Shi, L., Reid, L.H., Jones, W.D., Shippy, R., Warrington, J.A., Baker, S.C., Collins, P.J., de Longueville, F., Kawasaki, E.S., Lee, K.Y., Luo, Y., Sun, Y.A., Willey, J.C., Setterquist, R.A., Fischer, G.M., Tong, W., Dragan, Y.P., Dix, D.J., Frueh, F.W., Goodsaid, F.M., Herman, D., Jensen, R.V., Johnson, C.D., Lobenhofer, E.K., Puri, R.K., Schrf, U., Thierry-Mieg, J., Wang, C., Wilson, M., Wolber, P.K., Zhang, L., Amur, S., Bao, W., Barbacioru, C.C., Lucas, A.B., Bertholet, V., Boysen, C., Bromley, B., Brown, D., Brunner, A., Canales, R., Cao, X.M., Cebula, T.A., Chen, J.J., Cheng, J., Chu, T.M., Chudin, E., Corson, J., Corton, J.C., Croner, L.J., Davies, C., Davison, T.S., Delenstarr, G., Deng, X., Dorris, D., Eklund, A.C., Fan, X.H., Fang, H., Fulmer-Smentek, S., Fuscoe, J.C., Gallagher, K., Ge, W., Guo, L., Guo, X., Hager, J., Haje, P.K., Han, J., Han, T., Harbottle, H.C., Harris, S.C., Hatchwell, E., Hauser, C.A., Hester, S., Hong, H., Hurban, P., Jackson, S.A., Ji, H., Knight, C.R., Kuo, W.P., LeClerc, J.E., Levy, S., Li, Q.Z., Liu, C., Liu, Y., Lombardi, M.J., Ma, Y., Magnuson, S.R., Maqsodi, B., McDaniel, T., Mei, N., Myklebost, O., Ning, B., Novoradovskaya, N., Orr, M.S., Osborn, T.W., Papallo, A., Patterson, T.A., Perkins, R.G., Peters, E.H., Peterson, R., Philips, K.L., Pine, P.S., Pusztai, L., Qian, F., Ren, H., Rosen, M., Rosenzweig, B.A., Samaha, R.R., Schena, M., Schroth, G.P., Shchegrova, S., Smith, D.D., Staedtler, F., Su, Z., Sun, H., Szallasi, Z., Tezak, Z., Thierry-Mieg, D., Thompson, K.L., Tikhonova, I., Turpaz, Y., Vallanat, B., Van, C., Walker, S.J., Wang, S.J., Wang, Y., Wolfinger, R., Wong, A., Wu, J., Xiao, C., Xie, Q., Xu, J., Yang, W., Zhong, S., Zong, Y. and Slikker, W., Jr. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol., 24,1151–1161.
Guidance for Industry: Pharmacogenomic data submissions – Companion Guidance: Department of Health and Human Services (HHS), Food and Drug Administration (FDA), August 2007, http://www.fda.gov/cder/guidance/7735dft.pdf
Clinical Data Interchange Standard Consortium (CDISC): CDISC Inc., 15907 Two Rivers Cove, Austin, Texas 78717. (2007), http://www.cdisc.org/index.html
Tong, W., Harris, S., Cao, X., Fang, H., Shi, L., Sun, H., Fuscoe, J., Harris, A., Hong, H., Xie, Q., Perkins, R. and Casciano, D. (2004) Development of public toxicogenomics software for microarray data management and analysis. Mutat. Res., 549,241–253.
Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C.A., Causton, H.C., Gaasterland, T., Glenisson, P., Holstege, F.C., Kim, I.F., Markowitz, V., Matese, J.C., Parkinson, H., Robinson, A., Sarkans, U., Schulze-Kremer, S., Stewart, J., Taylor, R., Vilo, J. and Vingron, M. (2001) Minimum information about a microarray experiment (MIAME) – toward standards for microarray data. Nat. Genet., 29,365–371.
Quackenbush, J. (2002) Microarray data normalization and transformation. Nat. Genet., 32 Suppl,496–501.
Fielden, M.R., Halgren, R.G., Dere, E. and Zacharewski, T.R. (2002) GP3: GenePix post-processing program for automated analysis of raw microarray data. Bioinformatics, 18,771–773.
Tusher, V.G., Tibshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A., 98,5116–5121.
Chen, T., Guo, L., Zhang, L., Shi, L.M., Fang, H., Sun, Y.M., Fuscoe, J.C. and Mei, N. (2006) Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics, 7.
Sun, H., Fang, H., Chen, T., Perkins, R. and Tong, W. (2006) GOFFA: gene ontology for functional analysis – a FDA gene ontology tool for analysis of genomic and proteomic data. BMC Bioinformatics, 7 Suppl 2,S23.
Arlt, V.M., Ferluga, D., Stiborova, M., Pfohl-Leszkowicz, A., Vukelic, M., Ceovic, S., Schmeiser, H.H. and Cosyns, J.P. (2002) Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int. J. Cancer, 101,500–502.
Shav-Tal, Y. and Zipori, D. (2002) The role of activin a in regulation of hemopoiesis. Stem Cells, 20,493–500.
Fang, H., Perkins, R. and Tong, W. (2007) Omics integrating systems using ArrayTrack and other bioinformatics tools. Am. Drug Discov., 2,49–52.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Fang, H. et al. (2009). ArrayTrack: An FDA and Public Genomic Tool. In: Nikolsky, Y., Bryant, J. (eds) Protein Networks and Pathway Analysis. Methods in Molecular Biology, vol 563. Humana Press. https://doi.org/10.1007/978-1-60761-175-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-60761-175-2_20
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-174-5
Online ISBN: 978-1-60761-175-2
eBook Packages: Springer Protocols